Pulmonary diffusion impairment following heart transplantation: a prospective study

Area of Science:

• Pulmonary Physiology
• Cardiothoracic Surgery
• Transplantation Medicine

Background:

• Heart transplantation (HT) is a life-saving procedure, but post-operative complications require thorough investigation.
• Understanding lung function changes after HT is crucial for patient management and outcomes.
• Previous studies have not fully elucidated the timing and causes of impaired gas transfer post-HT.

Purpose of the Study:

• To determine if and when gas transfer declines after heart transplantation.
• To investigate the relationship between impaired gas transfer and hemodynamic changes, immunosuppression, and cytomegalovirus (CMV) infection.
• To compare lung function changes after HT with those after coronary artery bypass grafting (CABG).

Main Methods:

• Prospective study of 34 heart transplant recipients (HTR) and 14 control patients undergoing CABG.
• Measurement of lung function parameters including FEV1, FVC, RV, FRC, TLC, TL,CO, and KCO before and at multiple time points (30-150 days) post-procedure.
• Comparison of lung function data with hemodynamic status, graft rejection, cyclosporine levels, and CMV infection episodes.

Main Results:

• A significant fall in the carbon monoxide transfer coefficient (KCO) was observed after HT (pre-HT = 1.29 to post-HT = 1.06 mmol.min-1.kPa.L-1), but not after CABG (pre-CABG = 1.49 to post-CABG = 1.5 mmol.min-1.kPa.L-1).
• No correlation was found between gas transfer and CMV infection.
• A positive correlation was noted between TL,CO and KCO with cyclosporine levels at 150 days post-HT.

Conclusions:

• Early decline in gas transfer occurs after heart transplantation, independent of surgical effects.
• The observed decrease in gas transfer is likely attributable to early immunosuppressive therapy, particularly cyclosporine.
• Monitoring lung function post-HT is important, with potential links to immunosuppressive drug levels.